drug · oligonucleotide
patient view →cemdisiran
pre_registrationupdated 2mo agoby $REGN REGENERON PHARMACEUTICALS, INC.🔗 ChEMBL
community read0 votes
Oligonucleotide drug with a maximum clinical stage of Phase 3 (across all indications), with 5 investigational indications.
targets
Complement C5 mRNA
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that